Terms: = Breast cancer AND LYL1, P12980, 4066, ENSG00000104903 AND Staging
1 results:
1. The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced breast cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Blumencranz P; Habibi M; Shivers S; Acs G; Blumencranz LE; Yoder EB; van der Baan B; Menicucci AR; Dauer P; Audeh W; Cox CE
Ann Surg Oncol; 2023 Dec; 30(13):8353-8361. PubMed ID: 37658272
[TBL] [Abstract] [Full Text] [Related]
